HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

about

HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

Item

http://www.wikidata.org/entity/Q53250113

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年学术文章

@wuu

2015年学术文章

@zh

2015年学术文章

@zh-cn

2015年学术文章

@zh-hans

2015年学术文章

@zh-my

2015年学术文章

@zh-sg

2015年學術文章

@yue

2015年學術文章

@zh-hant

name

HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

@en

HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

@nl

type

Item

label

HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

@en

HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

@nl

prefLabel

HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

@en

HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

@nl

P1476

HepG2 cells acquire stem cell-like characteristics after immune cell stimulation.

@en

P2093

Binfeng Ji

http://www.w3.org/2001/XMLSchema#string

Chaotong Lin

http://www.w3.org/2001/XMLSchema#string

Chun Meng

http://www.w3.org/2001/XMLSchema#string

Guoying Shen

http://www.w3.org/2001/XMLSchema#string

Hang Wang

http://www.w3.org/2001/XMLSchema#string

Hongzhen Ren

http://www.w3.org/2001/XMLSchema#string

Ling Lin

http://www.w3.org/2001/XMLSchema#string

Miqing Yang

http://www.w3.org/2001/XMLSchema#string

Suling Lin

http://www.w3.org/2001/XMLSchema#string

P2860

Aldehyde dehydrogenase 1 is a marker for normal and malignant human colonic stem cells (SC) and tracks SC overpopulation during colon tumorigenesis

Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell

Cancer stem cells: mirage or reality?

Macrophages, innate immunity and cancer: balance, tolerance, and diversity

Isolation and in vitro propagation of tumorigenic breast cancer cells with stem/progenitor cell properties

Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study

The power and the promise of liver cancer stem cell markers.

GANT-61 inhibits pancreatic cancer stem cell growth in vitro and in NOD/SCID/IL2R gamma null mice xenograft

Multipotent cancer stem cells derived from human malignant peritoneal mesothelioma promote tumorigenesis.

Gli and hedgehog in cancer: tumours, embryos and stem cells.

P2888

s13402-015-0249-1

P304

35-45

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13402-015-0249-1

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-12-09T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26650484

http://www.w3.org/2001/XMLSchema#string